Discovery of potential biomarkers for osteoporosis diagnosis by individual omics and multi-omics technologies

被引:4
|
作者
Yang, Jing [1 ]
Wu, Jun [1 ,2 ]
机构
[1] Peking Univ, Beijing Jishuitan Hosp, Dept Clin Lab Med, Beijing, Peoples R China
[2] Peking Univ, Beijing Jishuitan Hosp, Dept Clin Lab Med, Beijing 100035, Peoples R China
关键词
Osteoporosis; multi-omics analysis; DNA methylation; microRNA; LncRNA; m6A; BONE-MINERAL DENSITY; POSTMENOPAUSAL OSTEOPOROSIS; BIOCHEMICAL MARKERS; TURNOVER MARKERS; DNA METHYLATION; FRACTURE RISK; HIP FRACTURE; IDENTIFICATION; ASSOCIATION; MICRORNAS;
D O I
10.1080/14737159.2023.2208750
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
IntroductionGlobal aging has made osteoporosis an increasingly serious public health problem. Osteoporotic fractures seriously affect the quality of life of patients and increase disability and mortality rates. Early diagnosis is important for timely intervention. The continuous development of individual- and multi-omics methods is helpful for the exploration and discovery of biomarkers for the diagnosis of osteoporosis.Areas coveredIn this review, we first introduce the epidemiological status of osteoporosis and then describe the pathogenesis of osteoporosis. Furthermore, the latest progress in individual- and multi-omics technologies for exploring biomarkers for osteoporosis diagnosis is summarized. Moreover, we clarify the advantages and disadvantages of the application of osteoporosis biomarkers obtained using the omics method. Finally, we put forward valuable views on the future research direction of diagnostic biomarkers of osteoporosis.Expert opinionOmics methods undoubtedly provide greatly contribute to the exploration of diagnostic biomarkers of osteoporosis; however, in the future, the clinical validity and clinical utility of the obtained potential biomarkers should be thoroughly examined. In addition, the improvement and optimization of the detection methods for different types of biomarkers and standardization of the detection process guarantee the reliability and accuracy of the detection results.
引用
收藏
页码:505 / 520
页数:16
相关论文
共 50 条
  • [21] Editorial: Multi-Omics Technologies for Optimizing Synthetic Biomanufacturing
    Kim, Young-Mo
    Petzold, Christopher J.
    Kerkhoven, Eduard J.
    Baker, Scott E.
    FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY, 2021, 9
  • [22] Multi-omics in IBD biomarker discovery: the missing links
    Metwaly, Amira
    Haller, Dirk
    NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2019, 16 (10) : 587 - 588
  • [23] Application of multi-omics technologies to decipher rabies pathogenesis
    Chienwichai, Peerut
    Rearntong, Onrapak
    THAI JOURNAL OF VETERINARY MEDICINE, 2020, 50 (02): : 129 - 136
  • [24] A multi-omics approach for kidney cancer biomarker discovery
    Zieren, R. C.
    Clark, D. J.
    Dong, L.
    Moreno, L. F.
    Kuczler, M. D.
    Amend, S. R.
    De Reijke, T. M.
    Pienta, K. J.
    EUROPEAN UROLOGY, 2021, 79 : S741 - S741
  • [25] Application of Multi-Omics Technologies to the Study of Phytochromes in Plants
    Wu, Shumei
    Gao, Yue
    Zhang, Qi
    Liu, Fen
    Hu, Weiming
    ANTIOXIDANTS, 2024, 13 (01)
  • [26] Multi-omics in IBD biomarker discovery: the missing links
    Amira Metwaly
    Dirk Haller
    Nature Reviews Gastroenterology & Hepatology, 2019, 16 : 587 - 588
  • [27] Multi-omics and potential applications in wine production
    Siren, Kimmo
    Maki, Sarah Siu Tze
    Fischer, Ulrich
    Hansen, Lars Hestbjerg
    Gilbert, M. Thomas P.
    CURRENT OPINION IN BIOTECHNOLOGY, 2019, 56 : 172 - 178
  • [28] Are multi-omics enough?
    Cristina Vilanova
    Manuel Porcar
    Nature Microbiology, 1 (8)
  • [29] Are multi-omics enough?
    Vilanova, Cristina
    Porcar, Manuel
    NATURE MICROBIOLOGY, 2016, 1 (08)
  • [30] CLINICAL MULTI-OMICS
    Radstake, Timothy R.
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 16 - 16